These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 36103090)

  • 1. Correction: Equilibration rate constant, k
    Masui K; Hagihira S
    J Anesth; 2022 Dec; 36(6):763. PubMed ID: 36103090
    [No Abstract]   [Full Text] [Related]  

  • 2. Equilibration rate constant, k
    Masui K; Hagihira S
    J Anesth; 2022 Dec; 36(6):757-762. PubMed ID: 36018387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population pharmacokinetic model of remimazolam for general anesthesia and consideration of remimazolam dose in clinical practice.
    Masui K; Stöhr T; Pesic M; Tonai T
    J Anesth; 2022 Aug; 36(4):493-505. PubMed ID: 35708787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of the plasma effect site equilibration rate constant (ke0) of propofol in children using the time to peak effect: comparison with adults.
    Muñoz HR; Cortínez LI; Ibacache ME; Altermatt FR
    Anesthesiology; 2004 Dec; 101(6):1269-74. PubMed ID: 15564932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of the effect-site equilibration rate constant using the time-to-peak effect of muscle relaxants measured by train-of-four stimulation during general anesthesia induction.
    Park SY; Kim HJ; Choi YS; Yun SH; Park JC
    Korean J Anesthesiol; 2018 Apr; 71(2):113-119. PubMed ID: 29619783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of a modified propofol equilibration rate constant (k(e0)) on the effect-site concentration at loss and recovery of consciousness with the Marsh model.
    Seo JH; Goo EK; Song IA; Park SH; Park HP; Jeon YT; Hwang JW
    Anaesthesia; 2013 Dec; 68(12):1232-8. PubMed ID: 24032636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of the plasma effect site equilibration rate constant of sufentanil in children using the time to peak effect of heart rate and blood pressure.
    Song IK; Lee JH; Jung S; Kim JT; Kim HS
    Indian J Pharmacol; 2015; 47(4):360-4. PubMed ID: 26288466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of target concentration, equilibration rate constant (ke0 ) and pharmacokinetic model on the initial propofol dose delivered in effect-site target-controlled infusion.
    Glen JB; Engbers FH
    Anaesthesia; 2016 Mar; 71(3):306-14. PubMed ID: 26682512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel technique to determine an 'apparent ke0 ' value for use with the Marsh pharmacokinetic model for propofol.
    Thomson AJ; Nimmo AF; Engbers FH; Glen JB
    Anaesthesia; 2014 May; 69(5):420-8. PubMed ID: 24738799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetic/pharmacodynamic modeling for remimazolam in the induction and maintenance of general anesthesia in healthy subjects and in surgical subjects.
    Zhou J; Leonowens C; Ivaturi VD; Lohmer LL; Curd L; Ossig J; Schippers F; Petersen KU; Stoehr T; Schmith V
    J Clin Anesth; 2020 Nov; 66():109899. PubMed ID: 32585566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of two Ke0 in the same pharmacokinetic propofol model: study on loss and recovery of consciousness.
    Simoni RF; Esteves LO; Miziara LE; Cangiani LM; Alves GG; Romano AL; Hansen PÚ; Vianna PT
    Rev Bras Anestesiol; 2011; 61(4):397-408. PubMed ID: 21724003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rocuronium pharmacodynamic models for published five pharmacokinetic models: age and sex are covariates in pharmacodynamic models.
    Masui K; Ishigaki S; Tomita A; Otake H
    J Anesth; 2018 Oct; 32(5):709-716. PubMed ID: 30099599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Continuous Infusion in Healthy Male Volunteers: Part I. Pharmacokinetics and Clinical Pharmacodynamics.
    Schüttler J; Eisenried A; Lerch M; Fechner J; Jeleazcov C; Ihmsen H
    Anesthesiology; 2020 Apr; 132(4):636-651. PubMed ID: 31972655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect-site concentration of remimazolam at loss and recovery of responsiveness during general anesthesia: a simulation study.
    Kim KM; Bang JY; Lee JM; Yang HS; Choi BM; Noh GJ
    Anesth Pain Med (Seoul); 2022 Jul; 17(3):262-270. PubMed ID: 35918858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the plasma effect-site equilibrium rate constant (Ke₀) of propofol by fitting time of loss and recovery of consciousness.
    Wu Q; Sun B; Wang S; Zhao L; Qi F
    Biol Pharm Bull; 2013; 36(9):1420-7. PubMed ID: 23803230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of parametric with semiparametric analysis of the concentration versus effect relationship of metocurine in dogs and pigs.
    Shafer SL; Varvel JR; Gronert GA
    J Pharmacokinet Biopharm; 1989 Jun; 17(3):291-304. PubMed ID: 2810069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The peak bispectral index time cannot predict early phase propofol pharmacodynamics with effect site-controlled infusion algorithm.
    Niu J; Wang SJ; Zhang MZ; Huang YL; Song L; Yu Q; Xu WY
    Indian J Pharmacol; 2012 Jan; 44(1):41-5. PubMed ID: 22345868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Origins of the Words : Zenshin Masui and Kyokusho Masui.].
    Matsuki A
    Masui; 2016 Sep; 65(8):853-857. PubMed ID: 30351603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-to-Event Modeling for Remimazolam for the Indication of Induction and Maintenance of General Anesthesia.
    Lohmer LL; Schippers F; Petersen KU; Stoehr T; Schmith VD
    J Clin Pharmacol; 2020 Apr; 60(4):505-514. PubMed ID: 31989598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychomotor Recovery Following Remimazolam-induced Sedation and the Effectiveness of Flumazenil as an Antidote.
    Chen X; Sang N; Song K; Zhong W; Wang H; Jiang J; Huang Y; Hu P
    Clin Ther; 2020 Apr; 42(4):614-624. PubMed ID: 32178858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.